dc.contributor.author |
Ponyi, Andrea |
|
dc.contributor.author |
Borgulya G, |
|
dc.contributor.author |
Constantin, Tamás |
|
dc.contributor.author |
Váncsa, Andrea |
|
dc.contributor.author |
Gergely, Lajos |
|
dc.contributor.author |
Dankó, Katalin |
|
dc.date.accessioned |
2018-06-20T13:10:58Z |
|
dc.date.available |
2018-06-20T13:10:58Z |
|
dc.date.issued |
2005 |
|
dc.identifier |
12344327640 |
|
dc.identifier.citation |
pagination=83-88;
journalVolume=44;
journalIssueNumber=1;
journalTitle=RHEUMATOLOGY (UNITED KINGDOM); |
|
dc.identifier.uri |
http://repo.lib.semmelweis.hu//handle/123456789/4260 |
|
dc.identifier.uri |
doi:10.1093/rheumatology/keh404 |
|
dc.description.abstract |
OBJECTIVES: To present the outcome of patients with idiopathic inflammatory myositis, focusing on functional ability and quality of life. METHODS: Analysis was performed using data from 105 adult patients with definitive polymyositis, dermatomyositis or overlap myositis, who were followed up at a single centre. The diagnosis was made between 1979 and 2000 based on Bohan and Peter's criteria. Functional ability was assessed after a minimum follow-up of 3 yr with the Health Assessment Questionnaire Disability Index (HAQDI) and quality of life was measured with the Short Form 36-item questionnaire (SF-36). RESULTS: Fifteen patients in our cohort died and 87 participated in the evaluation of functional outcome. Functional ability after a median follow-up of 107.1 months (range 36.4-273.3) was heterogeneous. The median HAQDI score was 0.875 (range 0-2.875). Polyphasic or chronic-progressive disease course, osteoporosis and long-term follow-up were predictive of higher HAQDI scores. In terms of quality of life, significant differences from population norms were shown in all domains of the SF-36. There were no significant differences in the SF-36 scores among the patients according to clinicopathological subset or disease course. CONCLUSIONS: Although the mortality of our cohort was favourable, myositis continues to have a great impact on life in the medium and long term. The present work indicates that myositis patients have a significantly poorer quality of life than the normal population, but there was no difference among the patients according to clinicopathological subsets. |
|
dc.relation.ispartof |
urn:issn:1462-0324 |
|
dc.title |
Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis |
|
dc.type |
Journal Article |
|
dc.date.updated |
2017-04-05T08:51:48Z |
|
dc.language.rfc3066 |
en |
|
dc.identifier.mtmt |
1633279 |
|
dc.identifier.wos |
000226187300015 |
|
dc.identifier.pubmed |
15381789 |
|
dc.contributor.department |
SE/AOK/K/II. Sz. Gyermekgyógyászati Klinika |
|
dc.contributor.institution |
Semmelweis Egyetem |
|